In the study, researchers tested the effects of a drug called riluzole, which is approved as a treatment for amyotrophic lateral sclerosis, a neuromuscular disorder
With the popularity of GLP-1 agonists on the rise, medications like Ozempic or Wegovy are becoming more and more common in people trying to lose weight
3,4 In fact, one study found that hair thinning was reported in almost 7% of people taking high-dose oral semaglutide, compared to less than 1% on placebo
The 23% substitution rate and extreme quantity accuracy variations documented in independent testing are disproportionately concentrated in this category
Her perspective highlights the importance of careful screening, eating disorder expertise, and individualized treatment decisions
Alsharari, S